Description
Omnicef 1gm Injection contains Cefotaxime, a third-generation cephalosporin antibiotic. It is used to treat a wide range of moderate to severe bacterial infections. Cefotaxime works by inhibiting bacterial cell wall synthesis, leading to bacterial death. This injection is NPPA regulated and is administered under medical supervision, typically in a hospital or clinic setting.
The 1gm dose is commonly used in adults or older children for severe infections.
Uses
-
Lower and upper respiratory tract infections – pneumonia, bronchitis, sinusitis, tonsillitis
-
Urinary tract infections (UTIs)
-
Skin and soft tissue infections
-
Bone and joint infections
-
Intra-abdominal infections (peritonitis, post-surgical infections)
-
Septicemia (bloodstream infections)
-
Meningitis (bacterial infection of the brain and spinal cord)
-
Gynecological infections
How It Works
Cefotaxime works by binding to penicillin-binding proteins (PBPs) in bacteria, preventing the formation of the bacterial cell wall. This causes the bacterial cell to weaken and die, effectively clearing the infection.
Side Effects
Common:
-
Pain, redness, or swelling at injection site
-
Nausea, vomiting, diarrhea
-
Rash, mild fever, headache
Serious (rare):
-
Severe allergic reactions (anaphylaxis, swelling, difficulty breathing)
-
Blood disorders (low platelets, anemia, leukopenia)
-
Liver enzyme elevation or jaundice
-
Clostridium difficile-associated diarrhea
Precautions
-
Avoid in patients allergic to cephalosporins or penicillins
-
Use with caution in renal or hepatic impairment (dose adjustment may be needed)
-
Not recommended for neonates with jaundice
-
Use in pregnancy and breastfeeding only under medical supervision
Administration
-
Administered via intravenous (IV) or intramuscular (IM) injection by a healthcare professional
-
Dosage depends on age, weight, infection type, and severity
-
The 1gm dose is typically used for adults and older children with moderate to severe infections
Leave a Reply